Paige N. Goulette

Neuromusculoskeletal Medicine

4200 Fashion Square Blvd Ste 301
Saginaw, MI 48603

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.

Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.

Journal: Multiple sclerosis journal - experimental, translational and clinical

Published: May 29, 2025

Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder: a case series report.

Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder: a case series report.

Journal: Frontiers in immunology

Published: November 12, 2024

Busting barriers for rare disease-A successful model of breaking barriers with payors for patient access to novel NMOSD therapeutics.

Busting barriers for rare disease-A successful model of breaking barriers with payors for patient access to novel NMOSD therapeutics.

Journal: Multiple sclerosis and related disorders

Published: April 30, 2024

Showing 1-3 of 3

Last Updated: 09/26/2026